A trial examining the use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for children undergoing microlaryngoscopy and bronchoscopy

Phase 2

Recruiting

• Conditions: Respiratory disease; Anaesthesiology - Anaesthetics; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12617000799358
• Lead Sponsor: Auckland District Health Board

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-05-31
• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

The principal inclusion criteria are male and female patients under the age of 13 years who are undergoing Microlaryngoscopy and Bronchoscopy.

Exclusion Criteria

Exclusion criteria are patients with a BMI (body mass index) greater than 35, severe nasal obstruction, patients with defects within the anterior skull base, inability to obtain informed parental consent, and emergency MLB when the time from being informed about the trial and time of surgery is less than 24 hours.
Children undergoing laser, diathermy or other forms of treatment associated with fires on or around their airway.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of patients in each group with hypoxia (desaturation <90% for 45 seconds or longer) using a pulse oximeter[ Any time throughout the duration of the operation (time from surgical start until finish)]